Aaron's Company, Inc. reported first quarter 2024 results: revenue Revenues were $511.5 million, EPS Loss per share was $0.46; Non-GAAP loss per share was $0.15. Guidance reaffirmed.
“of those results and the 2024 outlook are included below, in the attached supplement, and at investor.aarons.com . First Quarter 2024 Consolidated Results: • Revenues were $511.5 million • Adjusted EBITDA 1 was $22.7 million • Loss per share was $0.46; Non-GAAP loss per share 1 was $0.15 • Reaffirms full year 2024 outlook for revenue and adjusted EBITDA and”
MYPSPLAYSTUDIOS, Inc.
PLAYSTUDIOS, Inc. reported first quarter ended March 31, 2024 results: revenue $77.8 million, net income $0.6 million. Guidance reaffirmed.
“First Quarter Financial Highlights • Revenue was $77.8 million during the first quarter of 2024, compared to $80.1 million during the first quarter of 2023. • Net loss was $0.6 million during the first quarter of 2024, representing a net loss margin of (0.7)%, compared to net loss of $2.6 million during the first quarter of 2023, representing a net loss margin of (3.2)%.”
GPGIGPGI, Inc.
GPGI, Inc. reported first quarter ended March 31, 2024 results: revenue $104.0 million, net income $17.1 million, EPS $0.20 (Basic) and $0.17 (Diluted). Guidance reaffirmed.
“CompoSecure Reports Record First Quarter 2024 Financial Results and Declares Special Cash Dividend Q1 Net Sales up 9% to $104.0 Million; Q1 Net Income up 59% to $17.1 Million;”
FHTXFoghorn Therapeutics Inc.
Foghorn Therapeutics Inc. reported financial results for the quarter ended March 31, 2024.
“On May 6, 2024, Foghorn Therapeutics Inc. (the “Company”) issued a press release announcing certain of the Company’s financial results for the quarter ended March 31, 2024.”
RKLBRocket Lab Corp
Rocket Lab Corp reported second quarter of 2024 results: revenue between $105 million and $110 million. Guidance initiated.
“For the second quarter of 2024, Rocket Lab expects: • Revenue between $105 million and $110 million.”
RKLBRocket Lab Corp
Rocket Lab Corp reported financial results for first quarter ended March 31, 2024.
“Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today shared the financial results for fiscal first quarter ended March 31, 2024.”
OWLTOwlet, Inc.
Owlet, Inc. reported first quarter ended March 31, 2024 results: EPS Basic earnings per share was $0.15 for the first quarter of 2024, compared to basic net loss per share of ($1.54) for th.
“Q1 Revenue was approximately $14.8 million, up approximately 37% year over year.”
Matterport, Inc./DE
Matterport, Inc./DE reported financial results for the quarter ended March 31, 2024.
“On May 6, 2024, Matterport, Inc. (the “Company”) issued a press release announcing its financial and operational results for the first quarter of 2024. A copy of the press release is furnished as Exhibit 99.1 hereto.”
LCIDLucid Group, Inc.
Lucid Group, Inc. reported first quarter ended March 31, 2024 results: revenue $172.7 million.
“Lucid reported Q1 revenue of $172.7 million on deliveries of 1,967 vehicles”
ATI Physical Therapy, Inc.
ATI Physical Therapy, Inc. reported the first quarter ended March 31, 2024 results: revenue $181.5 million. Guidance reaffirmed.
“are presented after the financial statements at the end of this press release. Commentary on performance results in the first quarter of 2024 is as follows: • Net revenue was $181.5 million compared to $166.9 million in the first quarter of 2023, an increase of 8.7%. ▪ Net patient revenue was $165.4 million compared to $150.8 million in the first quarter of 2023, an”
ASRTAssertio Holdings, Inc.
Assertio Holdings, Inc. updated its three months ended March 31, 2024 guidance (reaffirmed).
“On May 6, 2024, Assertio Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2024.”
LYELLyell Immunopharma, Inc.
Lyell Immunopharma, Inc. reported the first quarter ended March 31, 2024 results: net income net loss of $60.7 million.
“Lyell reported a net loss of $60.7 million for the first quarter ended March 31, 2024, compared to a net loss of $67.0 million for the same period in 2023.”
LYELLyell Immunopharma, Inc.
Lyell Immunopharma, Inc. reported the quarter ended March 31, 2024 results: net income net loss of $60.7 million.
“On May 6, 2024, Lyell Immunopharma, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2024.”
ADEAAdeia Inc.
Adeia Inc. reported first quarter ended March 31, 2024 results: revenue $83.4 million, net income $0.9 million, EPS $0.01. Guidance reaffirmed.
“in markets that will drive future growth, including in OTT, adjacent media markets, and in our semiconductor business.” First Quarter Financial Highlights • Revenue was $83.4 million as compared to $86.9 million in the fourth quarter of 2023 • GAAP diluted earnings per share (EPS) was $0.01 and non-GAAP diluted EPS was $0.25 • GAAP net income was $0.9 million”
ORICOric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc. reported financial results for for the quarter ended March 31, 2024.
“ORIC Pharmaceuticals, Inc. issued a press release announcing its financial results for the fiscal quarter ended March 31, 2024.”
HIMSHims & Hers Health, Inc.
Hims & Hers Health, Inc. reported the first quarter ended March 31, 2024 results: revenue Revenue of $278.2 million, net income Net income of $11.1 million. Guidance raised.
“be expressly set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results Revenue of $278.2 million, up 46% year-over-year in 2024 Net income of $11.1 million; Adjusted EBITDA of $32.3 million in Q1 2024 Subscribers grew to 1.7 million, up 41% year-over-year in Q1 2024 Raises”
BRBRBELLRING BRANDS, INC.
BELLRING BRANDS, INC. updated its the second fiscal quarter ended March 31, 2024 guidance (raised).
“On May 6, 2024, BellRing Brands, Inc. (the "Company") issued a press release announcing results for its second fiscal quarter ended March 31, 2024.”
ADCTADC Therapeutics SA
ADC Therapeutics SA reported financial results for the first quarter ended March 31, 2024.
“On May 6, 2024, ADC Therapeutics SA (the “Company”) issued a press release announcing the Company’s financial results for the first quarter ended March 31, 2024.”
PNTGPennant Group, Inc.
Pennant Group, Inc. reported preliminary financial results for the first quarter ended March 31, 2024.
“On May 6, 2024 The Pennant Group, Inc. (the “Company” ) issued a press release reporting the financial results of the Company for its first quarter ended March 31, 2024.”
PLRXPLIANT THERAPEUTICS, INC.
PLIANT THERAPEUTICS, INC. reported first quarter ended March 31, 2024 results: net income Net loss of $47.0 million.
“Pliant Therapeutics, Inc. (the "Company") issued a press release announcing the Company’s financial results for the first quarter ended March 31, 2024.”
NWNNorthwest Natural Holding Co
Northwest Natural Holding Co reported the first quarter of 2024 results: net income $63.8 million, EPS $1.69 per share. Guidance reaffirmed.
“NW Natural Holdings Reports First Quarter 2024 Results”
VMDVIEMED HEALTHCARE, INC.
VIEMED HEALTHCARE, INC. reported three months ended March 31, 2024 results: revenue $50.6 million, net income $1.6 million.
“Net revenues for the quarter ended March 31, 2024 were $50.6 million , representing an increase of $11.0 million , or 28% , over net revenues reported for the comparable quarter ended March 31, 2023. • Net income for the quarter ended March 31, 2024 totaled $1.6 million.”
TALOTALOS ENERGY INC.
TALOS ENERGY INC. updated its the fiscal quarter ended March 31, 2024 guidance (reaffirmed).
“On May 6, 2024, Talos Energy Inc. (the “Company”) issued a press release announcing its financial and operational results for the fiscal quarter ended March 31, 2024.”
KRYSKrystal Biotech, Inc.
Krystal Biotech, Inc. reported the first quarter ending March 31, 2024 results: revenue $45.3 million.
“The Company recorded $45.3 million in VYJUVEK net product revenue for the first quarter of 2024.”
AMRAlpha Metallurgical Resources, Inc.
Alpha Metallurgical Resources, Inc. reported first quarter ending March 31, 2024 results: net income $127.0 million, EPS $9.59 per diluted share.
“Reports first quarter net income of $127.0 million, or $9.59 per diluted share”
JELDJELD-WEN Holding, Inc.
JELD-WEN Holding, Inc. reported the first quarter ended March 30, 2024 results: revenue $959.1 million, net income $(27.7) million, EPS $(0.32) per share. Guidance reaffirmed.
“the Company's Australasia segment as a discontinued operation, as appropriate and unless otherwise noted. First Quarter Highlights • Net revenues from continuing operations of $959.1 million decreased (11.2%) in the first quarter driven by a (12%) Core Revenue decline as a result of (12%) lower volume/mix due to weak macro-economic conditions. • Net loss from”
Playa Hotels & Resorts N.V.
Playa Hotels & Resorts N.V. updated its three months ended March 31, 2024 guidance (reaffirmed).
“On May 6, 2024, Playa Hotels & Resorts N.V. (“Playa” or the “Company”) issued a press release reporting the Company’s financial results for the three months ended March 31, 2024.”
CMTGClaros Mortgage Trust, Inc.
Claros Mortgage Trust, Inc. reported the quarter ended March 31, 2024 results: net income ($52.8 million), or ($0.39) per diluted share.
“Claros Mortgage Trust, Inc. Reports First Quarter 2024 Results New York, NY, May 6, 2024 – Claros Mortgage Trust, Inc. (NYSE: CMTG) (the “Company” or “CMTG”) today reported its financial results for the quarter ended March 31, 2024. The Company’s first quarter 2024 GAAP net loss was ($52.8 million), or ($0.39) per diluted share.”
BCSFBain Capital Specialty Finance, Inc.
Bain Capital Specialty Finance, Inc. reported first quarter ended March 31, 2024 results: revenue $74.5 million, net income $34.0 million or $0.53 per share, EPS $0.55.
“investments at fair value were in floating rate securities. RESULTS OF OPERATIONS For the three months ended March 31, 2024 and December 31, 2023, total investment income was $74.5 million and $74.9 million, respectively. The decrease in investment income was primarily due to a decrease in interest and dividend income, partially offset by an increase in other”
Shockwave Medical, Inc.
Shockwave Medical, Inc. reported first quarter ended March 31, 2024 results: revenue $218.8 million, net income $55.3 million, EPS $1.48 and $1.44.
“to bring our life-changing therapies to even more patients across the globe.” First Quarter 2024 Financial Results Revenue for the first quarter ended March 31, 2024, was $218.8 million, a 36% increase from $161.1 million in the same period of 2023. The growth in revenue was primarily driven by increased adoption of Shockwave products in both the United States”
EVEREverQuote, Inc.
EverQuote, Inc. reported the first quarter ended March 31, 2024 results: revenue $91.1 million, net income GAAP net income improved to $1.9 million. Guidance raised.
“by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 EverQuote Announces First Quarter 2024 Financial Results • First Quarter Revenue of $91.1 million • First Quarter Variable Marketing Margin of $30.8 million • First Quarter Record GAAP Net Income of $1.9 million and Adjusted EBITDA of $7.6 million CAMBRIDGE, Mass., May. 6,”
LITELumentum Holdings Inc.
Lumentum Holdings Inc. reported fiscal third quarter ended March 30, 2024 results: revenue $366.5 million, net income GAAP net loss of $127.0 million, EPS $1.88 per diluted share.
“Net revenue for the fiscal third quarter of 2024 was $366.5 million, with GAAP net loss of $127.0 million, or $1.88 per diluted share.”
CRVSCorvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc. reported financial results for the first quarter ended March 31, 2024.
“Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS) (GLOBAL NEWSWIRE), a clinical-stage biopharmaceutical company, today provided a business update and reported financial results for the first quarter ended March 31, 2024.”
STOKStoke Therapeutics, Inc.
Stoke Therapeutics, Inc. reported the three months ended March 31, 2024 results: revenue $4.2 million, net income $26.4 million, EPS $0.57 per share.
“Revenue recognized for upfront license fees and services provided from a License and Collaboration Agreement with Acadia Pharmaceuticals for the three months ended March 31, 2024 was $4.2 million, compared to $5.2 million, for the same period in 2023.”
NSANational Storage Affiliates Trust
National Storage Affiliates Trust reported first quarter 2024 results: net income $95.1 million, EPS $0.65.
“First Quarter 2024 Highlights • Reported net income of $95.1 million for the first quarter of 2024, an increase of 135.4% compared to the first quarter of 2023. Reported diluted earnings per share of $0.65 for the first quarter of 2024 compared to $0.24 for the first quarter of 2023.”
FRPTFreshpet, Inc.
Freshpet, Inc. reported the quarter ended March 31, 2024 results: revenue $223.8 million, net income $18.6 million. Guidance raised.
“(Nasdaq: FRPT) today reported financial results for its first quarter ended March 31, 2024 . First Quarter 2024 Financial Highlights Compared to Prior Year Period ● Net sales of $223.8 million, an increase of 33.6%. ● Gross margin of 39.4%, compared to the prior year period of 30.3%. ● Adjusted Gross Margin of 45.3%, compared to the prior year period of 38.5%. ● Net”
CBTCABOT CORP
CABOT CORP reported fiscal year 2024 results: EPS $6.65 to $6.85. Guidance raised.
“we are raising our Adjusted EPS guidance range for the fiscal year to $6.65 to $6.85 from our previously communicated range of $6.30 to $6.80.”
CBTCABOT CORP
CABOT CORP reported second quarter of fiscal 2024 results: net income $84 million, EPS $1.49 per common share. Guidance raised.
“For the second quarter of fiscal 2024, net income attributable to Cabot Corporation was $84 million ($1.49 per common share).”
NEWTNewtekOne, Inc.
NewtekOne, Inc. reported the three months ended March 31, 2024 results: net income Net income was $9.7 million, EPS $0.38 per basic and diluted common share. Guidance raised.
“Net income was $9.7 million, or $0.38 per basic and diluted common share for the three months ended March 31, 2024”
OGSONE Gas, Inc.
ONE Gas, Inc. reported first quarter 2024 results: net income $99.3 million, EPS $1.75 per diluted share. Guidance reaffirmed.
“First quarter 2024 net income was $99.3 million, or $1.75 per diluted share”
AXSMAxsome Therapeutics, Inc.
Axsome Therapeutics, Inc. reported first quarter of 2024 results: revenue $75.0 million, net income $68.4 million, EPS $(1.44) per share.
“Total net product revenue for the first quarter of 2024 was $75.0 million, representing 160% year-over-year growth.”
NINENine Energy Service, Inc.
Nine Energy Service, Inc. reported the quarter ended March 31, 2024 results: revenue $142.1 million, net income $(8.1) million, EPS $(0.24) per diluted share and $(0.24) per basic share.
“Act of 1933, as amended. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Nine Energy Service Announces First Quarter 2024 Results • Revenue, net loss and adjusted EBITDA A of $142.1 million, $(8.1) million and $15.0 million, respectively, for the first quarter of 2024 • Despite flat US rig count, increased gross profit in Q1 versus Q4 • Surpassed 60,000 Stinger TM”
CHMICherry Hill Mortgage Investment Corp
Cherry Hill Mortgage Investment Corp reported first quarter 2024 results: net income $9.7 million, or $0.32 per share, EPS $0.32 per basic and diluted weighted average common share outstanding.
“Cherry Hill Mortgage Investment Corporation (NYSE: CHMI) (“Cherry Hill” or the “Company”) today reported results for the first quarter 2024. First Quarter 2024 Highlights • GAAP net income applicable to common stockholders of $9.7 million, or $0.32 per share.”
WHLRWheeler Real Estate Investment Trust, Inc.
Wheeler Real Estate Investment Trust, Inc. reported financial results for the three months ended March 31, 2024.
“issued a press release announcing that it had reported its financial and operating results for the three months ended March 31, 2024”
Gatos Silver, Inc.
Gatos Silver, Inc. reported financial results for the quarter ended March 31, 2024.
“On May 6, 2024, Gatos Silver, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended March 31, 2024.”
VACMARRIOTT VACATIONS WORLDWIDE Corp
MARRIOTT VACATIONS WORLDWIDE Corp reported the quarter ended March 31, 2024 results: net income Net income attributable to common stockholders was $47 million, EPS fully diluted earnings per share was $1.22. Guidance reaffirmed.
“Marriott Vacations Worldwide Reports First Quarter 2024 Financial Results ORLANDO, Fla. – May 6, 2024 – Marriott Vacations Worldwide Corporation (NYSE: VAC) (“MVW,” the “Company,” “we” or “our”) reported first quarter 2024 financial results.”
T2 Biosystems, Inc.
T2 Biosystems, Inc. reported first quarter ended March 31, 2024 results: revenue $2.1 million, net income $13.5 million, EPS $2.66 per share. Guidance reaffirmed.
“financial and operational results for the first quarter ended March 31, 2024. Recent Financial and Operational Highlights • Achieved first quarter 2024 sepsis product revenue of $2.1 million, representing growth of 25% compared to the prior year period and sequential growth of 23% compared to the fourth quarter of 2023, led by T2Candida Panel sales and strong”
FLYYQSpirit Aviation Holdings, Inc.
Spirit Aviation Holdings, Inc. reported first quarter of 2024 results: revenue $1,265.5 million, net income $(142.6) million, EPS $(1.30).
“portion of the credits from Pratt & Whitney related to aircraft unavailable for service. First Quarter 2024 (unaudited) As Reported Adjusted 1 Total operating revenues $1,265.5 million $1,265.5 million Operating income (loss) $(207.3) million $(175.6) million Operating margin (16.4)% (13.9)% Adj. Operating income (loss), for AOG credits — $(146.6) million Adj.”
AIR LEASE CORP
AIR LEASE CORP reported the three months ended March 31, 2024 results: revenue $663.3, net income $97.4, EPS $0.87.
“ended March 31, 2024 and 2023 (in millions, except per share amounts and percentages): Operating Results Three Months Ended March 31, 2024 2023 $ change % change Revenues $ 663.3 $ 636.1 $ 27.2 4.3 % Operating expenses (528.0) (477.9) (50.1) 10.5 % Income before taxes 135.3 158.3 (23.0) (14.5) % Net income attributable to common stockholders $ 97.4 $ 118.3”
BWXTBWX Technologies, Inc.
BWX Technologies, Inc. reported first quarter ended March 31, 2024 results: revenue $604.0 million, net income $68.5 million, EPS $0.75. Guidance reaffirmed.
“BWX Technologies Reports First Quarter 2024 Results • 1Q24 revenues of $604.0 million • 1Q24 net income of $68.5 million, adjusted EBITDA (1) of $115.2 million • 1Q24 diluted GAAP EPS of $0.75, non-GAAP (1) EPS of $0.76 • Announced expansion of Cambridge manufacturing plant; enhancing capabilities to serve the global CANDU and Small Modular Reactor markets • Reaffirms 2024 non-GAAP EPS (1) guidance of $3.05-$3.20”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.